These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 20691638)
21. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058 [TBL] [Abstract][Full Text] [Related]
22. Tuberculosis. Part II. LoBue PA; Catanzaro A; Dutt AK; Stead W Dis Mon; 1997 Apr; 43(4):181-274. PubMed ID: 9146474 [No Abstract] [Full Text] [Related]
23. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations? Yew WW; Koh WJ Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853 [TBL] [Abstract][Full Text] [Related]
24. Why is long-term therapy required to cure tuberculosis? Connolly LE; Edelstein PH; Ramakrishnan L PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672 [TBL] [Abstract][Full Text] [Related]
25. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis]. Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452 [TBL] [Abstract][Full Text] [Related]
26. Anti-tuberculosis drug resistance in Dohuk, Iraq. Merza MA; Farnia P; Masjedi MR; Ridell M Int J Tuberc Lung Dis; 2010 Sep; 14(9):1213-4. PubMed ID: 20819274 [No Abstract] [Full Text] [Related]
27. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous? Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018 [No Abstract] [Full Text] [Related]
28. [Occurence of primary resistance in hospital patients with respiratory tuberculosis]. Serdarević H; Bogdanović M; Travnik H; Simeonov L Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090 [No Abstract] [Full Text] [Related]
29. Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. Zazueta-Beltran J; León-Sicairos N; Muro-Amador S; Flores-Gaxiola A; Velazquez-Roman J; Flores-Villaseñor H; Canizalez-Roman A Int J Infect Dis; 2011 Apr; 15(4):e272-6. PubMed ID: 21317004 [TBL] [Abstract][Full Text] [Related]
30. Assessment of resistance in multi drug resistant tuberculosis patients. Irfan S; Hassan Q; Hasan R J Pak Med Assoc; 2006 Sep; 56(9):397-400. PubMed ID: 17091751 [TBL] [Abstract][Full Text] [Related]
31. Pakistan's battle with multi-drug resistant tuberculosis--establishing the ground rules. Saleem T; Khalid U J Pak Med Assoc; 2012 Jan; 62(1):80. PubMed ID: 22352115 [No Abstract] [Full Text] [Related]
32. The early bactericidal activity of antituberculosis drugs. Diacon AH; Donald PR Expert Rev Anti Infect Ther; 2014 Feb; 12(2):223-37. PubMed ID: 24392698 [TBL] [Abstract][Full Text] [Related]
34. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A; Gogate A Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525 [TBL] [Abstract][Full Text] [Related]
35. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex]. Saito H; Sato K; Tomioka H Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649 [No Abstract] [Full Text] [Related]